2020
DOI: 10.4103/nnjcr.nnjcr_50_19
|View full text |Cite
|
Sign up to set email alerts
|

A 10-year review of progestogen-only injectable contraceptive use at a private facility in Lagos, Southwest Nigeria

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 17 publications
0
3
0
Order By: Relevance
“…These are the most common reasons why users abandon them (10, 11). Several studies confirm that injectable contraceptives cause sexual and libido problems after a certain period of use in Europe (12)(13)(14), the United States (15)(16)(17), and Central Africa (18,19). Although injectable contraceptive use remains low in sub-Saharan Africa with a slowly increasing tendency (11,20,21), side effects are already reported in this recent practice (18,22).…”
Section: Introductionmentioning
confidence: 95%
See 1 more Smart Citation
“…These are the most common reasons why users abandon them (10, 11). Several studies confirm that injectable contraceptives cause sexual and libido problems after a certain period of use in Europe (12)(13)(14), the United States (15)(16)(17), and Central Africa (18,19). Although injectable contraceptive use remains low in sub-Saharan Africa with a slowly increasing tendency (11,20,21), side effects are already reported in this recent practice (18,22).…”
Section: Introductionmentioning
confidence: 95%
“…Several studies confirm that injectable contraceptives cause sexual and libido problems after a certain period of use in Europe (12)(13)(14), the United States (15)(16)(17), and Central Africa (18,19). Although injectable contraceptive use remains low in sub-Saharan Africa with a slowly increasing tendency (11,20,21), side effects are already reported in this recent practice (18,22). It is the case of the Ivorian context that is marked by a low national contraceptive prevalence (13.9%) with important regional disparities; a high maternal mortality (614 deaths per 100,000 live births) while 38 deaths per 1,000 live births are deplored in neonatology and 108 deaths per 1,000 live births in children under 5 years of age (23).…”
Section: Introductionmentioning
confidence: 95%
“…Globally according to previously conducted studies the 12-month life-table discontinuation rate due to these side effects was 58%,with half of those who stopped after one injection 6 .The study of the factors of drop out of DMPA injections in Indonesia discovered that they want to conceive or have children right away 35.13% and that the negative side effects like delay in return to fertility after method discountution is the reason for their abandonment 10,11 . Medroxyprogesterone Acetate (MPA) tends to persist in the bloodstream and prevent ovulation for several months after DMPA administration is stopped 8,12 Different reports indicate that there is a variable delay in the resumption of menstruation, ovulation and fertility after DMPA is discontinued [13][14][15] .…”
Section: Introductionmentioning
confidence: 99%